mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
0.002 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.002 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |